HOME / CONTACT US
繁體版 / 简体版
 

MEDIA

Title Date
The Board of Directors Approved the 2022 Q2 Consolidated Financial Statements 2022-08-12
Announce the new appointment of the general manager 2022-08-12
Announcement of the BOD resolved to release of non-compete restrictions for the manager 2022-08-12
To announce the change of General Manager 2022-07-11
To announce the change of the spokesperson 2022-07-11
Announced BOD's resolution that the related matters of ex-rights and ex-dividend 2022-06-30
Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd.,the record date for dividend distribution. 2022-06-10
Microbio Co.,LTD. receives a R.O.C. patent on the new drug MS-20 (CHEMO YOUNG). 2022-06-01
To announce 2022 Shareholders' Meeting majoy resolutions. 2022-05-27
Approved the removal of restrictions imposed against the director for involving in competing businesses by the Annual General Shareholders' meeting. 2022-05-27
Announcement of the first quarter of Year 2022 consolidated financial reports were approved by the BOD 2022-05-11
Announce to modify the use of cash capital increase of 2007. 2022-05-11
Subsidiary received the unblinding data from CRO, engaged by Oneness, regarding US Phase II clinical trial of FB825 to treat moderate-to-severe atopic dermatitis. 2022-05-02
Microbio Ranked among Top 5% in the 8th Corporate Governance Evaluation 2022-04-29
Microbio Co., Ltd. receives a Brazil patent on the new drug MS-20 (CHEMO YOUNG). 2022-04-15
Announcement of Year 2021 consolidated financial reports were approved by the BOD 2022-03-15
Announcement of dividends distribution approved by the BOD 2022-03-15
Announcement of the resolution of the BOD to issue new shares through capitalization of capital surplus 2022-03-15
Board's resolution to convene the 2022 Annual General Meeting (Method of convening the meeting: hybrid shareholders' meeting) 2022-03-15
Announcement of the resolution of the BOD to convene the 2022 annual shareholders' meeting 2022-02-25